SCHEDULE 13G

Statement of Beneficial Ownership

Milestone Pharmaceuticals Inc. Filed 2025-12-23 Acc 0001969764-25-000003

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-08-07 SCHEDULE 13G Statement of Beneficial Ownership
2025-12-23 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-13 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)